Differential cytostatic and cytotoxic action of metallocorroles against human cancer cells: Potential platforms for anticancer drug development

Chemical Research in Toxicology

Volumn 25, Issue 2, 2012, Pages 400-409

  Lim, Punnajit ^a   Mahammed, Atif ^b   Okun, Zoya ^b   Saltsman, Irena ^b   Gross, Zeev ^b   Gray, Harry B ^c   Termini, John ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM; DOXORUBICIN; GALLIUM; MANGANESE; METAL ION;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE M PHASE; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN HCT116; CELLULAR DISTRIBUTION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; CYTOSTASIS; CYTOTOXICITY; DNA REPLICATION; DRUG DEVELOPMENT; HUMAN; HUMAN CELL; IC 50; MELANOMA; MELANOMA CELL; OVARY CANCER; PROSTATE CANCER;

CELL LINE, TUMOR; CELL SURVIVAL; CYTOSTATIC AGENTS; CYTOTOXINS; DRUG DESIGN; HUMANS; METALS; NEOPLASMS; ORGANOMETALLIC COMPOUNDS; PORPHYRINS;

EID: 84859752403     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx200452w     Document Type: Article

References (37)

1. American Cancer Society (2010) Cancer Facts & Figures 2010, American Cancer Society, Atlanta.
2. Jemal, A, Siegel, R, Xu, J., and Ward, E. (2010) Cancer statistics, 2010. CA: Cancer J. Clin. 60, 277.
3. Aviv-Harel, I., and Gross, Z. (2011) Coordination chemistry of corroles; with focus on main group elements. Coord. Chem. Rev. 255, 717-736.
4. Aviv-Harel, I., and Gross, Z. (2009) Aura of corroles. Chem. Eur. J. 15, 8382-8394.
5. Mahammed, A., Goldberg, I., and Gross, Z. (2001) Highly selective chlorosulfonation of tris(pentafluorophenyl)corrole as a synthetic tool for the preparation of amphiphilic corroles and metal complexes of planar chirality. Org. Lett. 3, 3443-3446. (Pubitemid 33625380)
6. Mahammed, A, and Gross, Z. (2005) Albumin-conjugated corrole metal complexes: Extremely simple yet very efficient biomimetic oxidation systems. J. Am. Chem. Soc. 127, 2883-2887. (Pubitemid 40349865)
7. Gershman, Z., Goldberg, I., and Gross, Z. (2007) DNA binding and catalytic properties of positively charged corroles. Angew. Chem. Int. Ed. 46, 4320-4324. (Pubitemid 47040830)
8. Ma, H, Zhang, M., Zhang, D., Huang, R, Zhao, Y., Yang, H, Liu, Y., Weng, X., Zhou, Y., Deng, M., Xu, L., and Zhou, X. (2010) Pyridyl-substituted corrole isomers: Synthesis and their regulation to G-quadruplex structures. Chem. - Asian J. 5, 114-122.
9. Saltsman, I., Botoshansky, M., and Gross, Z. (2008) Facile synthesis of orthopyridyl-substituted corroles and molecular structures of analogous porphyrins. Tetrahedron Lett. 49, 4163-4166.
10. Mahammed, A, Gray, H. B., Weaver, J. J., Sorasaenee, K, and Gross, Z. (2004) Amphiphilic corroles bind tightly to human serum albumin. Bioconjugate Chem. 15, 738-746. (Pubitemid 38981947)
11. Haber, A., Mahammed, A., Fuhrman, B., Volkova, N., Coleman, R, Hayek, T., Aviram, M., and Gross, Z. (2008) Amphiphilic/Bipolar metallocorroles that catalyze the decomposition of reactive oxygen and nitrogen species, rescue lipoproteins from oxidative damage, and attenuate atherosclerosis in mice. Angew. Chem. Int. Ed. 47, 7896-7900.
12. Haber, A., Agadjanian, H, Medina-Kauwe, L. K., and Gross, Z. (2008) Corroles that bind with high affinity to both apo and holo transferrin. J. Inorg. Biochem. 102, 446-457.
13. Agadjanian, H, Weaver, J. J., Mahammed, A., Rentsendorj, A., Bass, S., Kim, J., Dmochowski, I. J., Margalit, R, Gray, H. B., Gross, Z., and Medina-Kauwe, L. K (2006) Specific delivery of corroles to cells via noncovalent conjugates with viral proteins. Pharm. Res. 23, 367-377. (Pubitemid 43237866)
14. Agadjanian, H, Ma, J., Rentsendorj, A., Valluripalli, V., Hwang, J. Y., Mahammed, A., Farkas, D. L., Gray, H. B., Gross, Z., and Medina-Kauwe, L. K (2009) Tumor detection and elimination by a targeted gallium corrole. Proc. Natl. Acad. Sci. USA. 106, 6105-6110.
15. Aviezer, D., Cotton, S., David, M., Segev, A., Khaselev, N., Galili, N., Gross, Z., and Yayon, A. (2000) Porphyrin analogues as novel antagonists of fibroblast growth factor and vascular endothelial growth factor receptor binding that inhibit endothelial cell proliferation, tumor progression, and metastasis. Cancer Res. 60, 2973-2980. (Pubitemid 30395823)
16. Berg, K., Selbo, P. K., Weyergang, A., Dietze, A., Prasmickaite, L., Bonsted, A., Engesaeter, B. O., Angell-Petersen, E., Warloe, T., Frandsen, N., and Hogset, A. (2005) Porphyrin-related photo-sensitizers for cancer imaging and therapeutic applications. J. Microsc. 218, 133-147. (Pubitemid 40655323)
17. Shoemaker, R. H. (2006) The NCI60 human tumour cell line anticancer drug screen. Nature Rev. 6, 813-823. (Pubitemid 44450469)
18. Saltsman, I., Mahammed, A., Goldberg, I., Tkachenko, E., Botoshansky, M., and Gross, Z. (2002) Selective substitution of corroles: Nitration, hydroformylation, and chlorosulfonation. J. Am. Chem. Soc. 124, 7411-7420. (Pubitemid 34670449)
19. Haber, A., Aviram, M., and Gross, Z. (2011) Protecting the beneficial functionality of lipoproteins by 1-Fe, a corrole-based catalytic antioxidant. Chem. Sci. 2, 295-302.
20. Richardson, D. R. (2001) Iron and gallium increase iron uptake from transferrin by human melanoma cells: Further examination of the ferric ammonium citrate-activated iron uptake process. Biochim. Biophys. Acta 1536, 43-54. (Pubitemid 32378794)
21. Tampo, Y., Kotamraju, S., Chitambar, C. R., Kalivendi, S. V., Keszler, A., Joseph, J., and Kalyanaraman, B. (2003) Oxidative stress-induced iron signaling is responsible for peroxide-dependent oxidation of dichlorodihydrofluorescein in endothelial cells: Role of transferrin receptor-dependent iron uptake in apoptosis. Circ. Res. 92, 56-63. (Pubitemid 36105607)
22. Chitambar, C. R., Narasimhan, J., Guy, J., Sem, D. S., and O'Brien, W. J. (1991) Inhibition of ribonucleotide reductase by gallium in murine leukemic L1210 cells. Cancer Res. 51, 6199-6201.
23. Jakupec, M. A., and Keppler, B. K. (2004) Gallium in cancer treatment. Curr. Top. Med. Chem. 4, 1575-1583. (Pubitemid 39654451)
24. Chitambar, C. R. (2010) Medical applications and toxicities of gallium compounds. Int. J. Environ. Res. Public Health 7, 2337-2361.
25. Hedley, D. W., Tripp, E. H., Slowiaczek, P., and Mann, G. J. (1988) Effect of gallium on DNA synthesis by human T-cell lymphoblasts. Cancer Res. 48, 3014-3018.
26. Seidman, A. D., Scher, H. I., Heinemann, M. H., Bajorin, D. F., Sternberg, C. N., Dershaw, D. D., Silverberg, M., and Bosl, G. J. (1991) Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors. Cancer 68, 2561-2565.
27. Chitambar, C. R., Purpi, D. P., Woodliff, J., Yang, M., and Wereley, J. P. (2007) Development of gallium compounds for treatment of lymphoma: gallium maltolate, a novel hydroxypyrone gallium compound, induces apoptosis and circumvents lymphoma cell resistance to gallium nitrate. J. Pharmacol. Exp. Ther. 322, 1228-1236. (Pubitemid 47295794)
28. Chua, M. S., Bernstein, L. R., Li, R., and So, S. K. (2006) Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma. Anticancer Res. 26, 1739-1743. (Pubitemid 43989426)
29. Candide, C., Morliere, P., Maziere, J. C., Goldstein, S., Santus, R., Dubertret, L., Reyftmann, J. P., and Polonovski, J. (1986) In vitro interaction of the photoactive anticancer porphyrin derivative photofrin II with low density lipoprotein, and its delivery to cultured human fibroblasts. FEBS Lett. 207, 133-138. (Pubitemid 17179374)
30. Maziere, J. C., Morliere, P., and Santus, R. (1991) The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours. J. Photochem. Photobiol. B 8, 351-360.
31. Krishnamurthy, P. C., Du, G., Fukuda, Y., Sun, D., Sampath, J., Mercer, K. E., Wang, J., Sosa-Pineda, B., Murti, K. G., and Schuetz, J. D. (2006) Identification of a mammalian mitochondrial porphyrin transporter. Nature 443, 586-589. (Pubitemid 44527295)
32. Richardson, D., and Baker, E. (1992) Two mechanisms of iron uptake from transferrin by melanoma cells. The effect of desferrioxamine and ferric ammonium citrate. J. Biol. Chem. 267, 13972-13979.
33. Lovell, J. F., Jin, C. S., Huynh, E., Jin, H., Kim, C., Rubinstein, J. L., Chan, W. C., Cao, W., Wang, L. V., and Zheng, G. (2011) Porphysome nanovesicles generated by porphyrin bilayers for use as multimodal biophotonic contrast agents. Nat. Mater. 10, 324-332.
34. Pope, A. J., Bruce, C., Kysela, B., and Hannon, M. J. (2010) Issues surrounding standard cytotoxicity testing for assessing activity of non-covalent DNA-binding metallo-drugs. Dalton Trans. 39, 2772-2774.
35. Zaffaroni, N., Silvestrini, R., Orlandi, L., Bearzatto, A., Gornati, D., and Villa, R. (1998) Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells. Br. J. Cancer 77, 1378-1385. (Pubitemid 28190736)
36. Escudier, B., Eisen, T., Stadler, W. M., Szczylik, C., Oudard, S., Siebels, M., Negrier, S., Chevreau, C., Solska, E., Desai, A. A., Rolland, F., Demkow, T., Hutson, T. E., Gore, M., Freeman, S., Schwartz, B., Shan, M., Simantov, R., and Bukowski, R. M. (2007) Sorafenib in advanced clear-cell renal-cell carcinoma. N. Engl. J. Med. 356, 125-134. (Pubitemid 46089673)
37. Einhorn, L. H., Roth, B. J., Ansari, R., Dreicer, R., Gonin, R., and Loehrer, P. J. (1994) Phase II trial of vinblastine, ifosfamide, and gallium combination chemotherapy in metastatic urothelial carcinoma. J. Clin. Oncol. 12, 2271-2276. (Pubitemid 24346694)